Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Nephrology
•
Transplant nephrology
How much proteinuria would warrant consideration of native kidney nephrectomies at the time of a kidney transplant?
Related Questions
Should all kidney transplant patients be started on statin therapy post operatively given their increased risk of CVD?
Do you routinely use markers or tests other than serum creatinine when estimating GFR to determine if patients with liver failure, not on dialysis, meet criteria for a simultaneous liver-kidney transplant?
Do you recommend a metabolic evaluation in a kidney transplant patient with no prior history of nephrolithiasis who is found to have donor derived kidney stones?
How do you approach the management of a kidney transplant recipient who develops de novo donor-specific antibodies but shows no clinical signs of rejection or graft dysfunction?
How do you approach chronic active AMR concurrent with changes of CNI toxicity?
Do you have specific waiting periods before a patient can be listed for a kidney transplant if they have a past history of malignancy?
How do you distinguish TMA caused by CNI toxicity versus antibody mediated rejection in a kidney transplant patient?
What is your approach for patients with a history of nephrolithiasis who are being evaluated for living kidney donation?
What is your approach to dose adjusting mycophenolate in a kidney transplant recipient who is transitioned from tacrolimus to cyclosporine?
How do you approach treatment for patients with proliferative glomerulonephritis with monoclonal IgG deposits (PGNMID) with end-stage renal disease who are considering kidney transplant?
